Revolo Biotherapeutics
Peter Greenleaf currently serves as the chief executive officer (CEO) and member of the Board of Directors of Aurinia, (NASDAQ: AUPH / TSX: AUP), an autoimmune therapeutics company. He has held several other CEO and chairman roles. He is also currently a member of the Board of Directors of Antares Pharmaceuticals, Inc. (NASDAQ: ATRS) and Chairman of the Board of Directors of Biodelivery Sciences International, Inc. (NASDAQ: BDSI).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Revolo Biotherapeutics
Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.